| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |